Dr. Bradley Anawalt, Chief of Medicine at the University of Washington Medical Center and an endocrinology expert, joins to unravel the complexities of male hypogonadism. They discuss the critical factors for testing testosterone levels and the importance of lifestyle changes over immediate therapy. The conversation highlights risks associated with testosterone treatments, particularly concerning prostate health and cardiovascular risks. Anawalt also addresses secondary causes of hypogonadism and emphasizes individualized patient care in treatment decision-making.